Problem statement: Answer the MCQ question.
Question: Which drug exhibits a 4.946\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a. COc1cc(OC)cc(C(=O)Nc2ccn(C)n2)c1
b. Cc1ccc(N2C(=O)CN(Cc3sccc3C)C2=S)cc1C
c. O=C(CCCn1c(=S)[nH]c2ccccc2c1=O)N1CCN(c2cccc(Cl)c2)CC1
Answer: b. Cc1ccc(N2C(=O)CN(Cc3sccc3C)C2=S)cc1C
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1ccc(N2C(=O)CN(Cc3sccc3C)C2=S)cc1C
Cc1ccc(N2C(=O)CN(Cc3sccc3C)C2=S)cc1C
3-(3,4-dimethylphenyl)-1-[(3-methylthiophen-2-yl)methyl]-2-sulfanylideneimidazolidin-4-one